Lataa...
Nidogen-2: A New Serum Biomarker for Ovarian Cancer
OBJECTIVES: New ovarian cancer biomarkers suitable for early disease diagnosis, prognosis or monitoring could improve patient management and outcomes. DESIGN AND METHODS: Nidogen-2 was measured by immunoassay in serum of 100 healthy women, 100 women with benign gynecological conditions and 100 women...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3109863/ https://ncbi.nlm.nih.gov/pubmed/19883638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinbiochem.2009.10.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|